This ticker has not been starred yet ADMA Adma Biologics, Inc.
Biological Products (no Diagnostic Substances)
Book value per $ invested $ 0.12
Leverage 24.18%
Market Cap $ 3.7B
PE 17.93
Dividend Yield 0.00%
Profit $ 208.2m
Margin 42.77%

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures and markets plasma-derived biological products specialized for the treatment of immunodeficiencies and infectious diseases in the United States. The company is headquartered in Ramsey, New Jersey.

Subscribe Now For Access - Only $1.99 Per Month